Table 1.
Results for the six correlated variants associated with breast cancer-specific survival for patients with metastatic primary breast cancer at diagnosis.
| SNP | Chr | Position | Ref | Alt | EAF | r2 | HR | LCL | UCL | P value |
|---|---|---|---|---|---|---|---|---|---|---|
| rs138569520 | 1 | 226193175 | T | C | 0.02 | 0.87 | 3.67 | 1.86 | 7.23 | 3.19 × 10−8 |
| rs146023652 | 1 | 226158826 | C | T | 0.02 | 0.86 | 3.64 | 1.84 | 7.19 | 4.42 × 10−8 |
| rs114512448 | 1 | 226173980 | G | A | 0.02 | 0.86 | 3.53 | 1.78 | 6.95 | 6.57 × 10−8 |
| rs143653255 | 1 | 226157179 | T | C | 0.02 | 0.86 | 3.26 | 1.68 | 6.34 | 1.53 × 10−7 |
| rs115086585 | 1 | 226154721 | C | T | 0.02 | 0.85 | 3.21 | 1.64 | 6.25 | 2.93 × 10−7 |
| rs72757046 | 1 | 226235714 | G | C | 0.02 | 0.84 | 3.62 | 1.78 | 7.37 | 6.02 × 10−7 |
Genomic positions are based on the hg19 genome build.
ALT alternate, REF reference, EAF effect allele frequency, HR hazard rate, LCL lower control limit, UCL upper control limit, r2 imputation quality.